AtriCure (ATRC) Income from Continuing Operations (2010 - 2026)
AtriCure (ATRC) reported Income from Continuing Operations of 108000.0 for Q1 2026, up 101.6% year-over-year from 53571.24 in Q1 2025, and down 93.85% quarter-over-quarter from 1756000.0 in Q4 2025.
AtriCure (ATRC) Income from Continuing Operations (2010 - 2026) Analysis & Trends
AtriCure (ATRC) has 17 years of Income from Continuing Operations data on file, last reported at 108000.0 in Q1 2026.
- Income from Continuing Operations for Q1 2026 came in at 108000.0, up 101.6% year-over-year; the trailing twelve-month figure through Mar 2026 was 4593000.0 (up 87.97% YoY), and the FY2025 annual result was 11448000.0, up 74.39% from the prior year.
- Income from Continuing Operations retreated to 108000.0 in Q1 2026 per ATRC's latest filing, from 1756000.0 in the prior quarter.
- Over five years, Income from Continuing Operations peaked at 1756000.0 in Q4 2025 and troughed at 15568000.0 in Q4 2024.
- A 5-year average of 7820117.65 and a median of 7853000.0 in 2024 frame the typical range for Income from Continuing Operations.
- The sharpest annual moves came in 2023 and 2025: Income from Continuing Operations tumbled 134.75% in 2023, then jumped 111.28% in 2025.
- A 5-year view of Income from Continuing Operations shows it stood at 4170000.0 in 2022, then plunged by 134.75% to 9789000.0 in 2023, then plunged by 59.04% to 15568000.0 in 2024, then jumped by 111.28% to 1756000.0 in 2025, then sank by 93.85% to 108000.0 in 2026.
- Business Quant data shows ATRC's Income from Continuing Operations at 108000.0 in Q1 2026, 1756000.0 in Q4 2025, and 267000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 826.00 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -37.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 239.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 398.73 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 135.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 13.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -77.90 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 112.77 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -17.00 Mn |
| 10 | AtriCure | 1.34 Bn | 1.19 Bn | 109.31 Mn | 108,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 108,000.00 |
| Dec 31, 2025 | 1.76 Mn |
| Sep 30, 2025 | -267,000.00 |
| Jun 30, 2025 | -6.19 Mn |
| Mar 31, 2025 | -6.75 Mn |
| Dec 31, 2024 | -15.57 Mn |
| Sep 30, 2024 | -7.85 Mn |
| Jun 30, 2024 | -8.01 Mn |
| Mar 31, 2024 | -13.27 Mn |
| Dec 31, 2023 | -9.79 Mn |
| Sep 30, 2023 | -9.06 Mn |
| Jun 30, 2023 | -5.12 Mn |
| Mar 31, 2023 | -6.48 Mn |
| Dec 31, 2022 | -4.17 Mn |
| Sep 30, 2022 | -12.27 Mn |
| Jun 30, 2022 | -14.84 Mn |
| Mar 31, 2022 | -15.18 Mn |
| Dec 31, 2021 | -13.74 Mn |
| Sep 30, 2021 | 97.11 Mn |
| Jun 30, 2021 | -16.25 Mn |